Calithera Biosciences Reports Fourth Quarter and Full Year 2015 Financial Results and Recent Highlights

Go back to Calithera Biosciences Reports Fourth Quarter and Full Year 2015 Financial Results and Recent Highlights

Calithera Biosciences (CALA) Tops Q4 EPS by 12c

March 15, 2016 7:32 AM EDT

Calithera Biosciences (NASDAQ: CALA) reported Q4 EPS of ($0.44), $0.12 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Calithera Biosciences (CALA) click here.

... More